Skip to main navigation Skip to search Skip to main content

Adamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1

  • Steven Olson
  • , Susan D. Aster
  • , Kai Brown
  • , Linda Carbin
  • , Donald W. Graham
  • , Anne Hermanowski-Vosatka
  • , Cheryl B. LeGrand
  • , Steven S. Mundt
  • , Michael A. Robbins
  • , James M. Schaeffer
  • , Llnon H. Slossberg
  • , Michael J. Szymonifka
  • , Rolf Thieringer
  • , Samuel D. Wright
  • , James M. Balkovec
  • Merck

Research output: Contribution to journal › Article › peer-review

108 Scopus citations

Abstract

Adamantyl triazoles were identified as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). They are active both in in vitro and in in vivo pharmacodynamic models. The synthesis and structure-activity relationships of these inhibitors are presented.

Original languageEnglish
Pages (from-to)4359-4362
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume15
Issue number19
DOIs
StatePublished - 1 Oct 2005

Keywords

  • 11β-HSD1
  • Adamantyl triazole
  • Metabolic syndrome

Fingerprint

Dive into the research topics of 'Adamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1'. Together they form a unique fingerprint.

Cite this